{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:18:37Z","timestamp":1787872717356,"version":"build-2784847793"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06147-6","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:42:52Z","timestamp":1787870572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the Gap: Harnessing Phytochemical-Loaded Nanocarriers for Enhanced Epilepsy Treatment"],"prefix":"10.1007","volume":"63","author":[{"given":"Maryam","family":"Kazemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Besharatiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Jahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"11","key":"6147_CR1","doi-asserted-by":"publisher","first-page":"e29085","DOI":"10.1097\/MD.0000000000029085","volume":"101","author":"CQ Zhang","year":"2022","unstructured":"Zhang CQ, Li HY, Wan Y, Bai XY, Gan L, Sun HB (2022) Effect of different physical activity training methods on epilepsy: a protocol for systematic review and meta-analysis. Medicine 101(11):e29085. https:\/\/doi.org\/10.1097\/MD.0000000000029085","journal-title":"Medicine"},{"issue":"43","key":"6147_CR2","doi-asserted-by":"publisher","first-page":"12913","DOI":"10.1039\/d2sc03298h","volume":"13","author":"Q Hou","year":"2022","unstructured":"Hou Q, Wang L, Xiao F, Wang L, Liu X, Zhu L et al (2022) Dual targeting nanoparticles for epilepsy therapy. Chem Sci 13(43):12913\u201312920. https:\/\/doi.org\/10.1039\/d2sc03298h","journal-title":"Chem Sci"},{"issue":"1","key":"6147_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42494-023-00137-0","volume":"5","author":"KT Sumadewi","year":"2023","unstructured":"Sumadewi KT, Harkitasari S, Tjandra DC (2023) Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptol 5(1):28. https:\/\/doi.org\/10.1186\/s42494-023-00137-0","journal-title":"Acta Epileptol"},{"issue":"2","key":"6147_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/ene.14085","volume":"27","author":"TJ O\u2019Donohoe","year":"2020","unstructured":"O\u2019Donohoe TJ, Choudhury A, Callander E (2020) Global macroeconomic burden of epilepsy and the role for neurosurgery: a modelling study based upon the 2016 Global Burden of Disease data. Eur J Neurol 27(2):360\u2013368. https:\/\/doi.org\/10.1111\/ene.14085","journal-title":"Eur J Neurol"},{"issue":"2","key":"6147_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/epi.17155","volume":"63","author":"V Pironi","year":"2022","unstructured":"Pironi V, Ciccone O, Beghi E, Paragua\u2010Zuellig H, Patel AA, Giussani G et al (2022) Survey on the worldwide availability and affordability of antiseizure medications: report of the ILAE task force on access to treatment. Epilepsia 63(2):335\u2013351. https:\/\/doi.org\/10.1111\/epi.17155","journal-title":"Epilepsia"},{"issue":"2","key":"6147_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/brain\/awaa362","volume":"144","author":"C Steriade","year":"2021","unstructured":"Steriade C, Titulaer MJ, Vezzani A, Sander JW, Thijs RD (2021) The association between systemic autoimmune disorders and epilepsy and its clinical implications. Brain 144(2):372\u2013390. https:\/\/doi.org\/10.1093\/brain\/awaa362","journal-title":"Brain"},{"issue":"4","key":"6147_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ncl.2022.03.014","volume":"40","author":"S Toniolo","year":"2022","unstructured":"Toniolo S, Romoli M, Sen A (2022) Epilepsy in older persons. Neurol Clin 40(4):891\u2013905. https:\/\/doi.org\/10.1016\/j.ncl.2022.03.014","journal-title":"Neurol Clin"},{"issue":"1","key":"6147_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s42466-024-00313-8","volume":"6","author":"L Linka","year":"2024","unstructured":"Linka L, Magnus B, Faiz N, Habermehl L, Tsalouchidou P-E, Zahnert F et al (2024) First seizure in elderly patients: need to treat? Evidence from a retrospective study. Neurol Res Pract 6(1):20. https:\/\/doi.org\/10.1186\/s42466-024-00313-8","journal-title":"Neurol Res Pract"},{"issue":"11","key":"6147_CR9","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/epi.13913","volume":"58","author":"KM Aaberg","year":"2017","unstructured":"Aaberg KM, Sur\u00e9n P, S\u00f8raas CL, Bakken IJ, Lossius MI, Stoltenberg C et al (2017) Seizures, syndromes, and etiologies in childhood epilepsy: The International League Against Epilepsy 1981, 1989, and 2017 classifications used in a population-based cohort. Epilepsia 58(11):1880\u20131891. https:\/\/doi.org\/10.1111\/epi.13913","journal-title":"Epilepsia"},{"key":"6147_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59991","author":"M Heebner","year":"2024","unstructured":"Heebner M, Mainali G, Wei S, Kumar A, Naik S, Pradhan S et al (2024) Importance of genetic testing in children with generalized epilepsy. Cureus. https:\/\/doi.org\/10.7759\/cureus.59991","journal-title":"Cureus"},{"key":"6147_CR11","doi-asserted-by":"publisher","first-page":"108677","DOI":"10.1016\/j.yebeh.2022.108677","volume":"130","author":"H Tu","year":"2022","unstructured":"Tu H, Gong G, Zhang S, Fu Y, Wang T, Chu Q et al (2022) The association between illness perception and quality of life among Chinese adults with epilepsy: the mediating role of coping style. Epilepsy Behav 130:108677. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108677","journal-title":"Epilepsy Behav"},{"key":"6147_CR12","doi-asserted-by":"publisher","first-page":"109296","DOI":"10.1016\/j.yebeh.2023.109296","volume":"145","author":"A Gabrielsson","year":"2023","unstructured":"Gabrielsson A, Tromans S, Newman H, Triantafyllopoulou P, Hassiotis A, Bassett P et al (2023) Awareness of social care needs in people with epilepsy and intellectual disability. Epilepsy Behav 145:109296. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109296","journal-title":"Epilepsy Behav"},{"issue":"8","key":"6147_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.mpmed.2020.05.001","volume":"48","author":"L Harris","year":"2020","unstructured":"Harris L, Angus-Leppan H (2020) Epilepsy: diagnosis, classification and management. Medicine 48(8):522\u2013528. https:\/\/doi.org\/10.1016\/j.mpmed.2020.05.001","journal-title":"Medicine"},{"issue":"2","key":"6147_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani A, Fujinami RS, White HS, Preux PM, Bl\u00fcmcke I, Sander JW et al (2016) Infections, inflammation and epilepsy. Acta Neuropathol 131(2):211\u2013234. https:\/\/doi.org\/10.1007\/s00401-015-1481-5","journal-title":"Acta Neuropathol"},{"key":"6147_CR15","doi-asserted-by":"publisher","DOI":"10.2174\/011570159X323666241029171256","author":"YH Ng","year":"2025","unstructured":"Ng YH, Jamil SNH, Sarian MN, Ahmed QU, Latip J, Lam SD et al (2025) Antiseizure medications: advancements, challenges, and prospects in drug development. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/011570159X323666241029171256","journal-title":"Curr Neuropharmacol"},{"key":"6147_CR16","doi-asserted-by":"publisher","first-page":"120766","DOI":"10.1016\/j.jns.2023.120766","volume":"452","author":"B Mesraoua","year":"2023","unstructured":"Mesraoua B, Brigo F, Lattanzi S, Abou-Khalil B, Al Hail H, Asadi-Pooya AA (2023) Drug-resistant epilepsy: definition, pathophysiology, and management. J Neurol Sci 452:120766. https:\/\/doi.org\/10.1016\/j.jns.2023.120766","journal-title":"J Neurol Sci"},{"key":"6147_CR17","doi-asserted-by":"publisher","first-page":"1403232","DOI":"10.3389\/fphar.2024.1403232","volume":"15","author":"A Waris","year":"2024","unstructured":"Waris A, Ullah A, Asim M, Ullah R, Rajdoula MR, Bello ST et al (2024) Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action. Front Pharmacol 15:1403232. https:\/\/doi.org\/10.3389\/fphar.2024.1403232","journal-title":"Front Pharmacol"},{"issue":"7","key":"6147_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/17425247.2024.2384037","volume":"21","author":"O Katari","year":"2024","unstructured":"Katari O, Kumar K, Bhamble S, Jain S (2024) Gemini surfactants as next-generation drug carriers in cancer management. Expert Opin Drug Deliv 21(7):1029\u20131051. https:\/\/doi.org\/10.1080\/17425247.2024.2384037","journal-title":"Expert Opin Drug Deliv"},{"key":"6147_CR19","doi-asserted-by":"publisher","first-page":"106451","DOI":"10.1016\/j.jddst.2024.106451","volume":"104","author":"R Sharma","year":"2025","unstructured":"Sharma R, Yadav V, Katari O, Jain S (2025) Hyaluronic acid functionalized liposomes for co-delivery of paclitaxel and ursolic acid for enhanced efficacy against triple negative breast cancer. J Drug Deliv Sci Technol 104:106451. https:\/\/doi.org\/10.1016\/j.jddst.2024.106451","journal-title":"J Drug Deliv Sci Technol"},{"key":"6147_CR20","doi-asserted-by":"publisher","unstructured":"Trivedi R, Bonde S, Mate P, Umekar M, Wankhede N, Umare M, et al. (2025) Nose-to-brain targeting of pregabalin via phospholipid complex nanoparticles for facilitated epilepsy therapy: design, optimization and in vitro-in vivo evaluations. Colloids Surf A: Physicochem Eng Asp. 2025:138190. https:\/\/doi.org\/10.1016\/j.colsurfa.2025.138190.","DOI":"10.1016\/j.colsurfa.2025.138190"},{"issue":"6","key":"6147_CR21","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41401-025-01490-1","volume":"46","author":"W Jiang","year":"2025","unstructured":"Jiang W, Ma YY, Wang YF, Jin SQ, Yu RQ, Chu SX et al (2025) GABA transporter 1 is a promising drug target for CUL4B mutation-associated epilepsy. Acta Pharmacologica Sinica 46(6):1580\u201391. https:\/\/doi.org\/10.1038\/s41401-025-01490-1","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1","key":"6147_CR22","doi-asserted-by":"publisher","first-page":"27420","DOI":"10.1038\/srep27420","volume":"6","author":"K Tokudome","year":"2016","unstructured":"Tokudome K, Okumura T, Shimizu S, Mashimo T, Takizawa A, Serikawa T et al (2016) Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission. Sci Rep 6(1):27420. https:\/\/doi.org\/10.1038\/srep27420","journal-title":"Sci Rep"},{"issue":"3","key":"6147_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae135","volume":"6","author":"PA Whyte-Fagundes","year":"2024","unstructured":"Whyte-Fagundes PA, Vance A, Carroll A, Figueroa F, Manukyan C, Baraban SC (2024) Testing of putative antiseizure medications in a preclinical Dravet syndrome zebrafish model. Brain Commun 6(3). https:\/\/doi.org\/10.1093\/braincomms\/fcae135","journal-title":"Brain Commun"},{"issue":"7","key":"6147_CR24","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1021\/acs.jmedchem.2c01975","volume":"66","author":"T Hu","year":"2023","unstructured":"Hu T, Zhang J, Wang J, Sha L, Xia Y, Ortyl TC et al (2023) Advances in epilepsy: mechanisms, clinical trials, and drug therapies. J Med Chem 66(7):4434\u20134467. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01975","journal-title":"J Med Chem"},{"issue":"9","key":"6147_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","volume":"35","author":"W L\u00f6scher","year":"2021","unstructured":"L\u00f6scher W, Klein P (2021) The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs 35(9):935\u2013963. https:\/\/doi.org\/10.1007\/s40263-021-00827-8","journal-title":"CNS Drugs"},{"issue":"4","key":"6147_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2174\/0929867330666230117160632","volume":"31","author":"S-J Wang","year":"2024","unstructured":"Wang S-J, Zhao M-Y, Zhao P-C, Zhang W, Rao G-W (2024) Research status, synthesis and clinical application of antiepileptic drugs. Curr Med Chem 31(4):410\u2013452","journal-title":"Curr Med Chem"},{"issue":"1","key":"6147_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14581\/jer.25005","volume":"15","author":"H Hwang","year":"2025","unstructured":"Hwang H, Kim W-J (2025) Brivaracetam: pharmacology, clinical efficacy, and safety in epilepsy. J Epilepsy Res 15(1):42. https:\/\/doi.org\/10.14581\/jer.25005","journal-title":"J Epilepsy Res"},{"issue":"9","key":"6147_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40263-023-01027-2","volume":"37","author":"E Perucca","year":"2023","unstructured":"Perucca E, Bialer M, White HS (2023) New GABA-targeting therapies for the treatment of seizures and epilepsy: I. Role of GABA as a modulator of seizure activity and recently approved medications acting on the GABA system. CNS Drugs 37(9):755\u2013779. https:\/\/doi.org\/10.1007\/s40263-023-01027-2","journal-title":"CNS Drugs"},{"issue":"16","key":"6147_CR29","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1080\/14656566.2017.1392509","volume":"18","author":"C Di Bonaventura","year":"2017","unstructured":"Di Bonaventura C, Labate A, Maschio M, Meletti S, Russo E (2017) AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives. Expert Opin Pharmacother 18(16):1751\u20131764. https:\/\/doi.org\/10.1080\/14656566.2017.1392509","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"6147_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/ane.12879","volume":"137","author":"JJ Tsai","year":"2018","unstructured":"Tsai JJ, Wu T, Leung H, Desudchit T, Tiamkao S, Lim KS et al (2018) Perampanel, an AMPA receptor antagonist: from clinical research to practice in clinical settings. Acta Neurol Scand 137(4):378\u2013391. https:\/\/doi.org\/10.1111\/ane.12879","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"6147_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1212\/CPJ.0000000000000514","volume":"8","author":"DN Franz","year":"2018","unstructured":"Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R et al (2018) Everolimus for treatment-refractory seizures in TSC: extension of a randomized controlled trial. Neurol Clin Pract 8(5):412\u2013420. https:\/\/doi.org\/10.1212\/CPJ.0000000000000514","journal-title":"Neurol Clin Pract"},{"key":"6147_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.seizure.2021.10.011","volume":"93","author":"G Wiegand","year":"2021","unstructured":"Wiegand G, May TW, Lehmann I, Stephani U, Kadish NE (2021) Long-term treatment with everolimus in TSC-associated therapy-resistant epilepsies. Seizure 93:111\u2013119","journal-title":"Seizure"},{"issue":"4","key":"6147_CR33","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/epi4.12982","volume":"9","author":"A Gadhia","year":"2024","unstructured":"Gadhia A, Barker E, Morgan A, Barclay JW (2024) Functional analysis of epilepsy-associated GABAA receptor mutations using Caenorhabditis elegans. Epilepsia Open 9(4):1458\u20131466. https:\/\/doi.org\/10.1002\/epi4.12982","journal-title":"Epilepsia Open"},{"issue":"9","key":"6147_CR34","doi-asserted-by":"publisher","first-page":"8458","DOI":"10.3390\/ijms24098458","volume":"24","author":"GI Nwosu","year":"2023","unstructured":"Nwosu GI, Shen W, Zavalin K, Poliquin S, Randhave K, Flamm C et al (2023) GABAA receptor \u03b23 subunit mutation N328D heterozygous knock-in mice have Lennox-Gastaut syndrome. Int J Mol Sci 24(9):8458. https:\/\/doi.org\/10.3390\/ijms24098458","journal-title":"Int J Mol Sci"},{"key":"6147_CR35","doi-asserted-by":"publisher","first-page":"1042227","DOI":"10.3389\/fnbeh.2022.1042227","volume":"16","author":"N Wu","year":"2023","unstructured":"Wu N, Sun T, Wu X, Chen H, Zhang Z (2023) Modulation of GABAB receptors in the insula bidirectionally affects associative memory of epilectic rats in both spatial and non-spatial operant tasks. Front Behav Neurosci 16:1042227. https:\/\/doi.org\/10.3389\/fnbeh.2022.1042227","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"6147_CR36","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/brain\/awab343","volume":"145","author":"KL Lee","year":"2022","unstructured":"Lee KL, Abiraman K, Lucaj C, Ollerhead TA, Brandon NJ, Deeb TZ et al (2022) Inhibiting with-no-lysine kinases enhances K+\/Cl\u2212 cotransporter 2 activity and limits status epilepticus. Brain 145(3):950\u2013963. https:\/\/doi.org\/10.1093\/brain\/awab343","journal-title":"Brain"},{"issue":"1","key":"6147_CR37","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s41467-017-01749-0","volume":"8","author":"M Heubl","year":"2017","unstructured":"Heubl M, Zhang J, Pressey JC, Al Awabdh S, Renner M, Gomez-Castro F et al (2017) GABAA receptor dependent synaptic inhibition rapidly tunes KCC2 activity via the Cl\u2212-sensitive WNK1 kinase. Nat Commun 8(1):1776. https:\/\/doi.org\/10.1038\/s41467-017-01749-0","journal-title":"Nat Commun"},{"key":"6147_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.seizure.2017.07.014","volume":"51","author":"L Kambli","year":"2017","unstructured":"Kambli L, Bhatt LK, Oza M, Prabhavalkar K (2017) Novel therapeutic targets for epilepsy intervention. Seizure 51:27\u201334. https:\/\/doi.org\/10.1016\/j.seizure.2017.07.014","journal-title":"Seizure"},{"issue":"6","key":"6147_CR39","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1007\/s12035-023-03290-2","volume":"60","author":"D Khan","year":"2023","unstructured":"Khan D, Bedner P, M\u00fcller J, L\u00fclsberg F, Henning L, Prinz M et al (2023) TGF-\u03b2 activated kinase 1 (TAK1) is activated in microglia after experimental epilepsy and contributes to epileptogenesis. Mol Neurobiol 60(6):3413\u20133422. https:\/\/doi.org\/10.1007\/s12035-023-03290-2","journal-title":"Mol Neurobiol"},{"issue":"1","key":"6147_CR40","doi-asserted-by":"publisher","first-page":"16341","DOI":"10.1038\/s41598-025-01087-y","volume":"15","author":"M Wu","year":"2025","unstructured":"Wu M, Yu C, Wen F, Li Y, Zhang X, Wang Y et al (2025) NLRP3 inflammasome inhibits mitophagy during the progression of temporal lobe epilepsy. Sci Rep 15(1):16341. https:\/\/doi.org\/10.1038\/s41598-025-01087-y","journal-title":"Sci Rep"},{"issue":"9","key":"6147_CR41","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s11064-024-04176-y","volume":"49","author":"T Lu","year":"2024","unstructured":"Lu T, Chen X, Zhang Q, Shang K, Yang X, Xiang W (2024) Vitamin D relieves epilepsy symptoms and neuroinflammation in juvenile mice by activating the mTOR signaling pathway via RAF1: insights from network pharmacology and molecular docking studies. Neurochem Res 49(9):2379\u20132392. https:\/\/doi.org\/10.1007\/s11064-024-04176-y","journal-title":"Neurochem Res"},{"issue":"7","key":"6147_CR42","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/cbf.3306","volume":"35","author":"Z Qu","year":"2017","unstructured":"Qu Z, Su F, Qi X, Sun J, Wang H, Qiao Z et al (2017) Wnt\/\u03b2-catenin signalling pathway mediated aberrant hippocampal neurogenesis in kainic acid-induced epilepsy. Cell Biochem Funct 35(7):472\u2013476. https:\/\/doi.org\/10.1002\/cbf.3306","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"6147_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/biomedicines10020416","volume":"10","author":"W Lazarini-Lopes","year":"2022","unstructured":"Lazarini-Lopes W, Silva-Cardoso GK, Leite-Panissi CRA, Garcia-Cairasco N (2022) Increased TRPV1 channels and FosB protein expression are associated with chronic epileptic seizures and anxiogenic-like behaviors in a preclinical model of temporal lobe epilepsy. Biomedicines 10(2):416. https:\/\/doi.org\/10.3390\/biomedicines10020416","journal-title":"Biomedicines"},{"key":"6147_CR44","doi-asserted-by":"publisher","first-page":"174589","DOI":"10.1016\/j.ejphar.2021.174589","volume":"912","author":"Q Ren","year":"2021","unstructured":"Ren Q, Gao D, Mou L, Zhang S, Zhang M, Li N et al (2021) Anticonvulsant activity of melatonin and its success in ameliorating epileptic comorbidity-like symptoms in zebrafish. Eur J Pharmacol 912:174589. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174589","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"6147_CR45","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/biom15050654","volume":"15","author":"K Jackson","year":"2025","unstructured":"Jackson K, Shabat-Simon M, Bar-On J, Steckler R, Khatib S, Tamir S et al (2025) The anticonvulsant effects of different cannabis extracts in a zebrafish model of epilepsy. Biomolecules 15(5):654. https:\/\/doi.org\/10.3390\/biom15050654","journal-title":"Biomolecules"},{"issue":"3","key":"6147_CR46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1089\/can.2023.0067","volume":"9","author":"M Masoumi","year":"2024","unstructured":"Masoumi M, Manavi MA, Mohammad Jafari R, Mirzaei A, Hedayatyanfard K, Beigmohammadi MT et al (2024) Cannabidiol anticonvulsant effects against lithium-pilocarpine-induced status epilepticus in male rats are mediated by neuroinflammation modulation and cannabinoids 1 (CB1), but not CB2 and GABAA receptors. Cannabis Cannabinoid Res 9(3):797\u2013808. https:\/\/doi.org\/10.1089\/can.2023.0067","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"6147_CR47","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3390\/ijms23063063","volume":"23","author":"I Manna","year":"2022","unstructured":"Manna I, Fortunato F, De Benedittis S, Sammarra I, Bertoli G, Labate A et al (2022) Non-coding RNAs: new biomarkers and therapeutic targets for temporal lobe epilepsy. Int J Mol Sci 23(6):3063. https:\/\/doi.org\/10.3390\/ijms23063063","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6147_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12264-024-01215-0","volume":"40","author":"C Xu","year":"2024","unstructured":"Xu C, Wang Y, Chen Z (2024) Novel mechanism, drug target and therapy in epilepsy. Neurosci Bull 40(5):561\u2013563. https:\/\/doi.org\/10.1007\/s12264-024-01215-0","journal-title":"Neurosci Bull"},{"key":"6147_CR49","doi-asserted-by":"publisher","unstructured":"\u00c7akmak EN, G\u00fcr M, K\u0131ran B. (2022) Investigation of structure-activity relationships with molecular docking for some antiepileptic drugs and voltage-gated calcium (CaV) channels. Kastamonu Univ J Eng 6;8(1):28-53. https:\/\/doi.org\/10.55385\/kastamonujes.1094129.","DOI":"10.55385\/kastamonujes.1094129"},{"issue":"1","key":"6147_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42494-021-00055-z","volume":"3","author":"E Perucca","year":"2021","unstructured":"Perucca E (2021) The pharmacological treatment of epilepsy: recent advances and future perspectives. Acta Epileptol 3(1):22. https:\/\/doi.org\/10.1186\/s42494-021-00055-z","journal-title":"Acta Epileptol"},{"key":"6147_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114382","author":"K Nasrallah","year":"2024","unstructured":"Nasrallah K, Berthoux C, Hashimotodani Y, Ch\u00e1vez AE, Gulfo MC, Luj\u00e1n R et al (2024) Retrograde adenosine\/A2A receptor signaling facilitates excitatory synaptic transmission and seizures. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2024.114382","journal-title":"Cell Rep"},{"issue":"7","key":"6147_CR52","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.7150\/thno.100365","volume":"15","author":"M-J Sun","year":"2025","unstructured":"Sun M-J, Ren W-J, Zhao Y-F, Li X, Khan MT, Cheng X-Y et al (2025) Hippocampal P2X7 and A2A purinoceptors mediate cognitive impairment caused by long-lasting epileptic seizures. Theranostics 15(7):3159. https:\/\/doi.org\/10.7150\/thno.100365","journal-title":"Theranostics"},{"issue":"4","key":"6147_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/1389450122666210928145258","volume":"23","author":"M Guo","year":"2022","unstructured":"Guo M, Li T (2022) Adenosine dysfunction in epilepsy and associated comorbidities. Curr Drug Targets 23(4):344\u2013357. https:\/\/doi.org\/10.2174\/1389450122666210928145258","journal-title":"Curr Drug Targets"},{"issue":"33","key":"6147_CR54","doi-asserted-by":"publisher","first-page":"e2203632119","DOI":"10.1073\/pnas.2203632119","volume":"119","author":"D-F Huang","year":"2022","unstructured":"Huang D-F, Lee C-Y, Chou M-Y, Yang T-Y, Cao X, Hsiao Y-H et al (2022) Neuronal splicing regulator RBFOX3 mediates seizures via regulating Vamp1 expression preferentially in NPY-expressing GABAergic neurons. Proc Natl Acad Sci 119(33):e2203632119. https:\/\/doi.org\/10.1073\/pnas.2203632119","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"6147_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12987-024-00508-w","volume":"21","author":"V Tukacs","year":"2024","unstructured":"Tukacs V, Mittli D, Hunyadi-Guly\u00e1s \u00c9, Darula Z, Juh\u00e1sz G, Kardos J et al (2024) Comparative analysis of hippocampal extracellular space uncovers widely altered peptidome upon epileptic seizure in urethane-anaesthetized rats. Fluids Barriers CNS 21(1):6. https:\/\/doi.org\/10.1186\/s12987-024-00508-w","journal-title":"Fluids Barriers CNS"},{"key":"6147_CR56","doi-asserted-by":"publisher","first-page":"1037641","DOI":"10.3389\/fncel.2022.1037641","volume":"16","author":"AO Cuellar-Santoyo","year":"2023","unstructured":"Cuellar-Santoyo AO, Ruiz-Rodr\u00edguez VM, Mares-Barbosa TB, Patr\u00f3n-Soberano A, Howe AG, Portales-P\u00e9rez DP et al (2023) Revealing the contribution of astrocytes to glutamatergic neuronal transmission. Front Cell Neurosci 16:1037641. https:\/\/doi.org\/10.3389\/fncel.2022.1037641","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"6147_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11481-019-09902-w","volume":"15","author":"B Zhang","year":"2020","unstructured":"Zhang B, Wang L, Ji X, Zhang S, Sik A, Liu K et al (2020) Anti-inflammation associated protective mechanism of berberine and its derivatives on attenuating pentylenetetrazole-induced seizures in zebrafish. J Neuroimmune Pharmacol 15(2):309\u2013325. https:\/\/doi.org\/10.1007\/s11481-019-09902-w","journal-title":"J Neuroimmune Pharmacol"},{"key":"6147_CR58","doi-asserted-by":"publisher","first-page":"114406","DOI":"10.1016\/j.biopha.2023.114406","volume":"160","author":"S Javaid","year":"2023","unstructured":"Javaid S, Alqahtani F, Ashraf W, Anjum SMM, Rasool MF, Ahmad T et al (2023) Tiagabine suppresses pentylenetetrazole-induced seizures in mice and improves behavioral and cognitive parameters by modulating BDNF\/TrkB expression and neuroinflammatory markers. Biomed Pharmacother 160:114406. https:\/\/doi.org\/10.1016\/j.biopha.2023.114406","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"6147_CR59","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.3390\/molecules27092638","volume":"27","author":"T-Y Hsieh","year":"2022","unstructured":"Hsieh T-Y, Chang Y, Wang S-J (2022) Piperine provides neuroprotection against kainic acid-induced neurotoxicity via maintaining NGF signalling pathway. Molecules 27(9):2638. https:\/\/doi.org\/10.3390\/molecules27092638","journal-title":"Molecules"},{"issue":"1","key":"6147_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/epi4.12453","volume":"6","author":"AT Abdelmoity","year":"2021","unstructured":"Abdelmoity AT, Le Pichon JB, Abdelmoity SA, Sherman AK, Hall AS, Abdelmoity AT (2021) Combined use of the ketogenic diet and vagus nerve stimulation in pediatric drug-resistant epilepsy. Epilepsia Open 6(1):112\u2013119. https:\/\/doi.org\/10.1002\/epi4.12453","journal-title":"Epilepsia Open"},{"issue":"7","key":"6147_CR61","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1007\/s00210-024-02954-7","volume":"397","author":"H Montazerlotfelahi","year":"2024","unstructured":"Montazerlotfelahi H, Haj Mohamad Ebrahim Ketabforoush A, Tavakol M, Ashrafi M, Dehghani M, Mostafavi K et al (2024) Safety and efficacy of levetiracetam and carbamazepine monotherapy in the management of pediatric focal epilepsy: a randomized clinical trial. Naunyn Schmiedebergs Arch Pharmacol 397(7):5233\u201340. https:\/\/doi.org\/10.1007\/s00210-024-02954-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"6147_CR62","doi-asserted-by":"publisher","first-page":"110139","DOI":"10.1016\/j.yebeh.2024.110139","volume":"161","author":"S Auvin","year":"2024","unstructured":"Auvin S, Specchio N (2024) Pharmacotherapeutic strategies for drug-resistant epilepsy in children. Epilepsy Behav 161:110139. https:\/\/doi.org\/10.1016\/j.yebeh.2024.110139","journal-title":"Epilepsy Behav"},{"key":"6147_CR63","doi-asserted-by":"publisher","unstructured":"Trevelyan AJ, Marks VS, Graham RT, Denison T, Jackson A, Smith EH. On brain stimulation in epilepsy. Brain. 2025:awae385. https:\/\/doi.org\/10.1101\/2025.09.12.25335307.","DOI":"10.1101\/2025.09.12.25335307"},{"issue":"12","key":"6147_CR64","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S1474-4422(21)00300-8","volume":"20","author":"P Ryvlin","year":"2021","unstructured":"Ryvlin P, Rheims S, Hirsch LJ, Sokolov A, Jehi L (2021) Neuromodulation in epilepsy: state-of-the-art approved therapies. Lancet Neurol 20(12):1038\u20131047. https:\/\/doi.org\/10.1016\/S1474-4422(21)00300-8","journal-title":"Lancet Neurol"},{"key":"6147_CR65","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S256699","author":"D Guery","year":"2021","unstructured":"Guery D, Rheims S (2021) Clinical management of drug resistant epilepsy: a review on current strategies. Neuropsychiatr Dis Treat. https:\/\/doi.org\/10.2147\/NDT.S256699","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"6147_CR66","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3390\/ijms21072340","volume":"21","author":"B Miziak","year":"2020","unstructured":"Miziak B, Konarzewska A, U\u0142amek-Kozio\u0142 M, Dudra-Jastrz\u0119bska M, Pluta R, Czuczwar SJ (2020) Anti-epileptogenic effects of antiepileptic drugs. Int J Mol Sci 21(7):2340. https:\/\/doi.org\/10.3390\/ijms21072340","journal-title":"Int J Mol Sci"},{"key":"6147_CR67","doi-asserted-by":"publisher","first-page":"604040","DOI":"10.3389\/fphar.2021.604040","volume":"12","author":"L-Y He","year":"2021","unstructured":"He L-Y, Hu M-B, Li R-L, Zhao R, Fan L-H, He L et al (2021) Natural medicines for the treatment of epilepsy: bioactive components, pharmacology and mechanism. Front Pharmacol 12:604040. https:\/\/doi.org\/10.3389\/fphar.2021.604040","journal-title":"Front Pharmacol"},{"issue":"4","key":"6147_CR68","doi-asserted-by":"publisher","first-page":"E040624230683","DOI":"10.2174\/0122103155289394240522110321","volume":"15","author":"E Aleebrahim-Dehkordi","year":"2025","unstructured":"Aleebrahim-Dehkordi E, Jafari A, Bala AA, Lagzian A, Ghoshouni H, Koochaki P et al (2025) Targeting the receptor complexes by structure-based natural drug compounds in seizures: a new dimension in drug discovery and design. J Nat Prod 15(4):E040624230683. https:\/\/doi.org\/10.2174\/0122103155289394240522110321","journal-title":"J Nat Prod"},{"key":"6147_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.757729","volume":"13","author":"K Zhong","year":"2022","unstructured":"Zhong K, Qian C, Lyu R, Wang X, Hu Z, Yu J et al (2022) Anti-epileptic effect of crocin on experimental temporal lobe epilepsy in mice. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.757729","journal-title":"Front Pharmacol"},{"key":"6147_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39203","author":"M Khodadadi","year":"2024","unstructured":"Khodadadi M, Jahromi GP, Meftahi GH, Khodadadi H, Hadipour M, Ezami M (2024) Crocin nano-chitosan-coated compound mitigates hippocampal blood-brain barrier disruption, anxiety, and cognitive deficits in chronic immobilization stress-induced rats. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39203","journal-title":"Heliyon"},{"issue":"1","key":"6147_CR71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/RNN-160696","volume":"35","author":"X Zhang","year":"2017","unstructured":"Zhang X, Fan Z, Jin T (2017) Crocin protects against cerebral-ischemia-induced damage in aged rats through maintaining the integrity of blood-brain barrier. Restor Neurol Neurosci 35(1):65\u201375. https:\/\/doi.org\/10.3233\/RNN-160696","journal-title":"Restor Neurol Neurosci"},{"issue":"2","key":"6147_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.54548\/njps.v38i2.7","volume":"38","author":"AG Bakre","year":"2023","unstructured":"Bakre AG, Adeoluwa O, Adeoluwa G, Adeniyi F, Oni J, Akinluyi E et al (2023) Quercetin exerts anticonvulsant effect through mitigation of neuroinflammatory response in pentylenetetrazole-induced seizure in mice. Niger J Physiol Sci 38(2):187\u2013193. https:\/\/doi.org\/10.54548\/njps.v38i2.7","journal-title":"Niger J Physiol Sci"},{"key":"6147_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2023.102307","volume":"132","author":"NFG El-Tahawy","year":"2023","unstructured":"El-Tahawy NFG, Rifaai RA, Saber EA, Abd El-Aleem SA, Mohammed HH (2023) Neuroprotective effect of quercetin nanoparticles: a possible prophylactic effect in cerebellar neurodegenerative disorders. J Chem Neuroanat 132. https:\/\/doi.org\/10.1016\/j.jchemneu.2023.102307","journal-title":"J Chem Neuroanat"},{"key":"6147_CR74","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.eplepsyres.2023.107087","volume":"190","author":"L Dlugosz","year":"2023","unstructured":"Dlugosz L, Zhou HZ, Scott BW, Burnham M (2023) The effects of cannabidiol and \u03949-tetrahydrocannabinol, alone and in combination, in the maximal electroshock seizure model. Epilepsy Res 190:107087. https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107087","journal-title":"Epilepsy Res"},{"issue":"6","key":"6147_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060466","volume":"13","author":"Y Javadzadeh","year":"2024","unstructured":"Javadzadeh Y, Santos A, Aquilino MS, Mylvaganam S, Urban K, Carlen PL (2024) Cannabidiol exerts anticonvulsant effects alone and in combination with \u03949-THC through the 5-HT1A receptor in the neocortex of mice. Cells 13(6). https:\/\/doi.org\/10.3390\/cells13060466","journal-title":"Cells"},{"key":"6147_CR76","doi-asserted-by":"publisher","first-page":"1627465","DOI":"10.3389\/fphar.2025.1627465","volume":"16","author":"VA Martinez-Rojas","year":"2025","unstructured":"Martinez-Rojas VA, M\u00e1rquez LA, Martinez-Aguirre C, Sollozo-Dupont I, L\u00f3pez Preza FI, Fuentes Mej\u00eda M et al (2025) Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy. Front Pharmacol 16:1627465. https:\/\/doi.org\/10.3389\/fphar.2025.1627465","journal-title":"Front Pharmacol"},{"issue":"8","key":"6147_CR77","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/15353702231151976","volume":"248","author":"J Zhu","year":"2023","unstructured":"Zhu J, Park S, Kim CH, Jeong KH, Kim W-J (2023) Eugenol alleviates neuronal damage via inhibiting inflammatory process against pilocarpine-induced status epilepticus. Exp Biol Med 248(8):722\u2013731. https:\/\/doi.org\/10.1177\/15353702231151976","journal-title":"Exp Biol Med"},{"key":"6147_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-34650-8","author":"SM Baraka","year":"2026","unstructured":"Baraka SM, Hussien YA, Ahmed-Farid OA, Hassan A, Saleh DO (2026) Neuroprotective potential of eugenol against acrylamide-induced brain toxicity by regulating Nrf2\/NQO1\/HO-1 and NLRP3\/NF-\u03baB\/IL-1\u03b2 signaling cascades. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-34650-8","journal-title":"Sci Rep"},{"issue":"1","key":"6147_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12640-022-00628-x","volume":"41","author":"S Kundu","year":"2023","unstructured":"Kundu S, Singh S (2023) Protective mechanisms of 3-acetyl-11-keto-\u03b2-boswellic acid and piperine in fluid percussion rat model of traumatic brain injury targeting Nrf2 and NFkB signaling. Neurotox Res 41(1):57\u201384. https:\/\/doi.org\/10.1007\/s12640-022-00628-x","journal-title":"Neurotox Res"},{"key":"6147_CR80","doi-asserted-by":"publisher","first-page":"155892","DOI":"10.1016\/j.phymed.2024.155892","volume":"132","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zhang P, Ya D, Liu J, Xu Y, Zhang Y et al (2024) Withaferin a protects against epilepsy by promoting LCN2-mediated astrocyte polarization to stopping neuronal ferroptosis. Phytomedicine 132:155892. https:\/\/doi.org\/10.1016\/j.phymed.2024.155892","journal-title":"Phytomedicine"},{"issue":"7","key":"6147_CR81","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1002\/jnr.70064","volume":"103","author":"S Hong","year":"2025","unstructured":"Hong S, GuoYan L, JiaWen W, Xin Y, ShuQin Z, HongWei R et al (2025) Curcumin prevents neuronal loss and inhibits development of spontaneous recurrent seizures via the PPAR\u03b3\/PTEN\/Akt pathway in chronic epilepsy. J Neurosci Res 103(7):e70064. https:\/\/doi.org\/10.1002\/jnr.70064","journal-title":"J Neurosci Res"},{"issue":"2","key":"6147_CR82","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","volume":"15","author":"KK Cheng","year":"2013","unstructured":"Cheng KK, Yeung CF, Ho SW, Chow SF, Chow AH, Baum L (2013) Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. The AAPS J 15(2):324\u2013336. https:\/\/doi.org\/10.1208\/s12248-012-9444-4","journal-title":"The AAPS J"},{"key":"6147_CR83","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S487628","author":"Q Yang","year":"2024","unstructured":"Yang Q, Li R, Hong Y, Liu H, Jian C, Zhao S (2024) Curcumin-loaded gelatin nanoparticles cross the blood-brain barrier to treat ischemic stroke by attenuating oxidative stress and neuroinflammation. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S487628","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"6147_CR84","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/pharmaceutics16070849","volume":"16","author":"F Susa","year":"2024","unstructured":"Susa F, Arpicco S, Pirri CF, Limongi T (2024) An overview on the physiopathology of the blood\u2013brain barrier and the lipid-based nanocarriers for central nervous system delivery. Pharmaceutics 16(7):849. https:\/\/doi.org\/10.3390\/pharmaceutics16070849","journal-title":"Pharmaceutics"},{"issue":"7","key":"6147_CR85","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11011-024-01401-z","volume":"39","author":"Q Fang","year":"2024","unstructured":"Fang Q, Cai Y, Yang Y, Zhang J, Ke J, Luo J et al (2024) Curcumin attenuated neuroinflammation via the TLR4\/MyD88\/NF-\u03baB signaling way in the juvenile rat hippocampus following kainic acid-induced epileptic seizures. Metab Brain Dis 39(7):1387\u20131403. https:\/\/doi.org\/10.1007\/s11011-024-01401-z","journal-title":"Metab Brain Dis"},{"issue":"3","key":"6147_CR86","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00221-023-06557-1","volume":"241","author":"F Nikbakht","year":"2023","unstructured":"Nikbakht F, Hashemi P, Vazifekhah S, Babaei JF (2023) Investigating the mechanism of antiepileptogenic effect of apigenin in kainate temporal lobe epilepsy: possible role of mTOR. Exp Brain Res 241(3):753\u2013763. https:\/\/doi.org\/10.1007\/s00221-023-06557-1","journal-title":"Exp Brain Res"},{"issue":"2","key":"6147_CR87","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1134\/S181971242402003X","volume":"18","author":"H Eksik","year":"2024","unstructured":"Eksik H, Ankarali S, Torun IE, Kilinc E, Ankarali H (2024) The anti-convulsant effects of carvacrol in penicillin- and pentylenetetrazole-induced rat models of epilepsy. Neurochem J 18(2):296\u2013305. https:\/\/doi.org\/10.1134\/S181971242402003X","journal-title":"Neurochem J"},{"key":"6147_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156222","volume":"135","author":"Y Hu","year":"2024","unstructured":"Hu Y, Qi H, Yang J, Wang F, Peng X, Chen X et al (2024) Wogonin mitigates microglia-mediated synaptic over-pruning and cognitive impairment following epilepsy. Phytomedicine 135. https:\/\/doi.org\/10.1016\/j.phymed.2024.156222","journal-title":"Phytomedicine"},{"issue":"2","key":"6147_CR89","doi-asserted-by":"publisher","first-page":"673","DOI":"10.5530\/ijper.20250368","volume":"59","author":"G Yang","year":"2025","unstructured":"Yang G, Cai R (2025) The effect of kaempferol on cortical Nlrp3\/caspase-1\/Gsdmd mediated cell pyroptosis in chronic epileptic rats. Indian J Pharm Educ Res 59(2):673\u201381. https:\/\/doi.org\/10.5530\/ijper.20250368","journal-title":"Indian J Pharm Educ Res"},{"key":"6147_CR90","doi-asserted-by":"publisher","first-page":"118408","DOI":"10.1016\/j.jep.2024.118408","volume":"333","author":"J Yan","year":"2024","unstructured":"Yan J, Li T, Ji K, Zhou X, Yao W, Zhou L et al (2024) Safranal alleviates pentetrazole-induced epileptic seizures in mice by inhibiting the NF-\u03baB signaling pathway and mitochondrial-dependent apoptosis through GSK-3\u03b2 inactivation. J Ethnopharmacol 333:118408. https:\/\/doi.org\/10.1016\/j.jep.2024.118408","journal-title":"J Ethnopharmacol"},{"key":"6147_CR91","doi-asserted-by":"publisher","unstructured":"Ghanem HB, Emam MN, Mohammed ADA, Nagi A-ER. Impact of berberine on some epigenetic, transcription regulation and inflammatory biomarkers in a mice model of epilepsy. Rep Biochem Mol Biol. 2021;10(3):362. https:\/\/doi.org\/10.52547\/rbmb.10.3.362.","DOI":"10.52547\/rbmb.10.3.362"},{"key":"6147_CR92","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2023.07.004","volume":"675","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhu C, Jin Y, Shen W, Pan Y, Shen Y (2023) Ginsenoside Rg1 improved learning and memory ability and reduces neuronal apoptosis in epileptic rats through ERK\/CREB\/BDNF signal pathway. Biochem Biophys Res Commun 675:26\u201332. https:\/\/doi.org\/10.1016\/j.bbrc.2023.07.004","journal-title":"Biochem Biophys Res Commun"},{"key":"6147_CR93","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S314076","author":"J Yang","year":"2021","unstructured":"Yang J, Jia Z, Xiao Z, Zhao J, Lu Y, Chu L et al (2021) Baicalin rescues cognitive dysfunction, mitigates neurodegeneration, and exerts anti-epileptic effects through activating TLR4\/MYD88\/Caspase-3 pathway in rats. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S314076","journal-title":"Drug Des Devel Ther"},{"key":"6147_CR94","doi-asserted-by":"publisher","first-page":"109772","DOI":"10.1016\/j.intimp.2023.109772","volume":"116","author":"Z Tavakoli","year":"2023","unstructured":"Tavakoli Z, Dehkordi HT, Lorigooini Z, Rahimi-Madiseh M, Korani MS, Amini-Khoei H (2023) Anticonvulsant effect of quercetin in pentylenetetrazole (PTZ)-induced seizures in male mice: the role of anti-neuroinflammatory and anti-oxidative stress. Int Immunopharmacol 116:109772. https:\/\/doi.org\/10.1016\/j.intimp.2023.109772","journal-title":"Int Immunopharmacol"},{"key":"6147_CR95","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2022.09.001","volume":"191","author":"R Xie","year":"2022","unstructured":"Xie R, Zhao W, Lowe S, Bentley R, Hu G, Mei H et al (2022) Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway. Free Radic Biol Med 191:212\u2013226. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.09.001","journal-title":"Free Radic Biol Med"},{"key":"6147_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122347","volume":"336","author":"H Zhu","year":"2024","unstructured":"Zhu H, Wu Z, Yu Y, Chang K, Zhao C, Huang Z et al (2024) Integrated non-targeted metabolomics and network pharmacology to reveal the mechanisms of berberine in the long-term treatment of PTZ-induced epilepsy. Life Sci 336. https:\/\/doi.org\/10.1016\/j.lfs.2023.122347","journal-title":"Life Sci"},{"issue":"9","key":"6147_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091233","volume":"12","author":"W L\u00f6scher","year":"2023","unstructured":"L\u00f6scher W, White HS (2023) Animal models of drug-resistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments. Cells 12(9). https:\/\/doi.org\/10.3390\/cells12091233","journal-title":"Cells"},{"issue":"4","key":"6147_CR98","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4103\/RPS.RPS_68_24","volume":"19","author":"S Kakebaraei","year":"2024","unstructured":"Kakebaraei S, Gholami M, Nasta TZ, Arkan E, Bahrehmand F, Fakhri S et al (2024) Oral administration of crocin-loaded solid lipid nanoparticles inhibits neuroinflammation in a rat model of epileptic seizures by activating SIRT1 expression. Res Pharm Sci 19(4):397\u2013414. https:\/\/doi.org\/10.4103\/RPS.RPS_68_24","journal-title":"Res Pharm Sci"},{"key":"6147_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122759","volume":"636","author":"B S\u00e1nchez-Dengra","year":"2023","unstructured":"S\u00e1nchez-Dengra B, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, Gonz\u00e1lez-\u00c1lvarez M (2023) Access to the CNS: strategies to overcome the BBB. Int J Pharm 636. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122759","journal-title":"Int J Pharm"},{"issue":"1","key":"6147_CR100","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther 8(1):217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"6147_CR101","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/cns.14355","volume":"29","author":"A Movahedpour","year":"2023","unstructured":"Movahedpour A, Taghvaeefar R, Asadi-Pooya AA, Karami Y, Tavasolian R, Khatami SH et al (2023) Nano-delivery systems as a promising therapeutic potential for epilepsy: current status and future perspectives. CNS Neurosci Ther 29(11):3150\u20133159. https:\/\/doi.org\/10.1111\/cns.14355","journal-title":"CNS Neurosci Ther"},{"issue":"22","key":"6147_CR102","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1021\/acsomega.0c01592","volume":"5","author":"J Ahlawat","year":"2020","unstructured":"Ahlawat J, Guillama Barroso G, Masoudi Asil S, Alvarado M, Armendariz I, Bernal J et al (2020) Nanocarriers as potential drug delivery candidates for overcoming the blood\u2013brain barrier: challenges and possibilities. ACS Omega 5(22):12583\u201312595. https:\/\/doi.org\/10.1021\/acsomega.0c01592","journal-title":"ACS Omega"},{"issue":"21","key":"6147_CR103","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.3390\/ijms222111654","volume":"22","author":"RG Pinheiro","year":"2021","unstructured":"Pinheiro RG, Coutinho AJ, Pinheiro M, Neves AR (2021) Nanoparticles for targeted brain drug delivery: what do we know? Int J Mol Sci 22(21):11654. https:\/\/doi.org\/10.3390\/ijms222111654","journal-title":"Int J Mol Sci"},{"key":"6147_CR104","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejpb.2020.01.005","volume":"149","author":"MI Teixeira","year":"2020","unstructured":"Teixeira MI, Lopes C, Amaral MH, Costa P (2020) Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Eur J Pharm Biopharm 149:192\u2013217. https:\/\/doi.org\/10.1016\/j.ejpb.2020.01.005","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"6147_CR105","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43094-022-00414-8","volume":"8","author":"J Garg","year":"2022","unstructured":"Garg J, Pathania K, Sah SP, Pawar SV (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future J Pharm Sci 8(1):25. https:\/\/doi.org\/10.1186\/s43094-022-00414-8","journal-title":"Future J Pharm Sci"},{"key":"6147_CR106","doi-asserted-by":"publisher","first-page":"111084","DOI":"10.1016\/j.cbi.2024.111084","volume":"397","author":"A Ghosh","year":"2024","unstructured":"Ghosh A, Khanam N, Nath D (2024) Solid lipid nanoparticle: a potent vehicle of the kaempferol for brain delivery through the blood-brain barrier in the focal cerebral ischemic rat. Chem Biol Interact 397:111084. https:\/\/doi.org\/10.1016\/j.cbi.2024.111084","journal-title":"Chem Biol Interact"},{"key":"6147_CR107","doi-asserted-by":"publisher","first-page":"124686","DOI":"10.1016\/j.ijpharm.2024.124686","volume":"665","author":"R Vargas","year":"2024","unstructured":"Vargas R, Lizano-Barrantes C, Romero M, Valencia-Clua K, Narvaez-Narvaez DA, Sune-Negre JM et al (2024) The piper at the gates of brain: a systematic review of surface modification strategies on lipid nanoparticles to overcome the blood-brain-barrier. Int J Pharm 665:124686. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124686","journal-title":"Int J Pharm"},{"issue":"8","key":"6147_CR108","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.7150\/thno.95476","volume":"14","author":"A Dhull","year":"2024","unstructured":"Dhull A, Zhang Z, Sharma R, Dar AI, Rani A, Wei J et al (2024) Discovery of 2-deoxy glucose surfaced mixed layer dendrimer: a smart neuron targeted systemic drug delivery system for brain diseases. Theranostics 14(8):3221. https:\/\/doi.org\/10.7150\/thno.95476","journal-title":"Theranostics"},{"issue":"10","key":"6147_CR109","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1021\/acsabm.4c00999","volume":"7","author":"B Kruse","year":"2024","unstructured":"Kruse B, Dash BS, Kostka K, Wolff N, Prymak O, Loza K et al (2024) Doxorubicin-loaded ultrasmall gold nanoparticles (1.5 nm) for brain tumor therapy and assessment of their biodistribution. ACS Appl Bio Mater 7(10):6890\u20136907. https:\/\/doi.org\/10.1021\/acsabm.4c00999","journal-title":"ACS Appl Bio Mater"},{"issue":"3","key":"6147_CR110","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1166\/jbn.2022.3284","volume":"18","author":"Z Li","year":"2022","unstructured":"Li Z, Xu C, Wang Y (2022) Poly d, l-(lactic-co-glycolic) acid PEGylated isoliquiritigenin alleviates traumatic brain injury by reversing cyclooxygenase 2 level. J Biomed Nanotechnol 18(3):909\u2013916. https:\/\/doi.org\/10.1166\/jbn.2022.3284","journal-title":"J Biomed Nanotechnol"},{"issue":"6","key":"6147_CR111","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/pharmaceutics15061772","volume":"15","author":"C Puricelli","year":"2023","unstructured":"Puricelli C, Gigliotti CL, Stoppa I, Sacchetti S, Pantham D, Scomparin A et al (2023) Use of poly lactic-co-glycolic acid nano and micro particles in the delivery of drugs modulating different phases of inflammation. Pharmaceutics 15(6):1772. https:\/\/doi.org\/10.3390\/pharmaceutics15061772","journal-title":"Pharmaceutics"},{"key":"6147_CR112","doi-asserted-by":"publisher","first-page":"105788","DOI":"10.1016\/j.jddst.2024.105788","volume":"97","author":"P Anjali","year":"2024","unstructured":"Anjali P, Jawahar N, Kumar MP, Jubie S, Selvamuthukumar S (2024) Nanocarriers in the treatment of epilepsy: challenges and opportunities. J Drug Deliv Sci Technol 97:105788. https:\/\/doi.org\/10.1016\/j.jddst.2024.105788","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"6147_CR113","doi-asserted-by":"publisher","first-page":"20230010","DOI":"10.1515\/gps-2023-0010","volume":"12","author":"KM Mohamed","year":"2023","unstructured":"Mohamed KM, Abdelfattah MS, El-khadragy M, Al-Megrin WA, Fehaid A, Kassab RB et al (2023) Rutin-loaded selenium nanoparticles modulated the redox status, inflammatory, and apoptotic pathways associated with pentylenetetrazole-induced epilepsy in mice. Green Process Synth 12(1):20230010. https:\/\/doi.org\/10.1515\/gps-2023-0010","journal-title":"Green Process Synth"},{"key":"6147_CR114","doi-asserted-by":"publisher","first-page":"118081","DOI":"10.1016\/j.lfs.2020.118081","volume":"257","author":"CU Yilmaz","year":"2020","unstructured":"Yilmaz CU, Emik S, Orhan N, Temizyurek A, Atis M, Akcan U et al (2020) Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats. Life Sci 257:118081. https:\/\/doi.org\/10.1016\/j.lfs.2020.118081","journal-title":"Life Sci"},{"issue":"6","key":"6147_CR115","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics17060706","volume":"17","author":"L Ding","year":"2025","unstructured":"Ding L, Kshirsagar P, Agrawal P, Murry DJ (2025) Crossing the blood\u2013brain barrier: innovations in receptor- and transporter-mediated transcytosis strategies. Pharmaceutics 17(6):706. https:\/\/doi.org\/10.3390\/pharmaceutics17060706","journal-title":"Pharmaceutics"},{"issue":"9","key":"6147_CR116","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/app11094305","volume":"11","author":"L Del Amo","year":"2021","unstructured":"Del Amo L, Cano A, Ettcheto M, Souto EB, Espina M, Camins A et al (2021) Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer\u2019s disease. Appl Sci 11(9):4305. https:\/\/doi.org\/10.3390\/app11094305","journal-title":"Appl Sci"},{"issue":"1","key":"6147_CR117","doi-asserted-by":"publisher","first-page":"4557622","DOI":"10.1155\/ijbm\/4557622","volume":"2025","author":"E Ibarra-Ram\u00edrez","year":"2025","unstructured":"Ibarra-Ram\u00edrez E, Montes M, Urrutia RA, Reginensi D, Segura Gonz\u00e1lez EA, Estrada-Petrocelli L et al (2025) Metallic nanoparticles applications in neurological disorders: a review. Int J Biomater 2025(1):4557622. https:\/\/doi.org\/10.1155\/ijbm\/4557622","journal-title":"Int J Biomater"},{"issue":"10","key":"6147_CR118","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1007\/s11064-023-03955-3","volume":"48","author":"K Mishra","year":"2023","unstructured":"Mishra K, Rana R, Tripathi S, Siddiqui S, Yadav PK, Yadav PN et al (2023) Recent advancements in nanocarrier-assisted brain delivery of phytochemicals against neurological diseases. Neurochem Res 48(10):2936\u20132968. https:\/\/doi.org\/10.1007\/s11064-023-03955-3","journal-title":"Neurochem Res"},{"key":"6147_CR119","doi-asserted-by":"publisher","first-page":"114822","DOI":"10.1016\/j.addr.2023.114822","volume":"197","author":"R Qiao","year":"2023","unstructured":"Qiao R, Fu C, Forgham H, Javed I, Huang X, Zhu J et al (2023) Magnetic iron oxide nanoparticles for brain imaging and drug delivery. Adv Drug Deliv Rev 197:114822. https:\/\/doi.org\/10.1016\/j.addr.2023.114822","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"6147_CR120","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1016\/j.xphs.2022.09.012","volume":"111","author":"L Mihailova","year":"2022","unstructured":"Mihailova L, Tchekalarova J, Shalabalija D, Geskovski N, Gjorgievska VS, Stefkov G et al (2022) Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment\u2013in vitro characterization and in vivo efficacy studies. J Pharm Sci 111(12):3384\u20133396. https:\/\/doi.org\/10.1016\/j.xphs.2022.09.012","journal-title":"J Pharm Sci"},{"issue":"1","key":"6147_CR121","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s43094-023-00512-1","volume":"9","author":"HO Ammar","year":"2023","unstructured":"Ammar HO, Shamma RN, Yousry C, Elbatanony RS, Khater B, Ghoneim AM (2023) Characterization, cellular uptake in Caco-2 cells and physiologically based pharmacokinetic modeling of baicalin-loaded solid lipid nanoparticles. Future J Pharm Sci 9(1):61. https:\/\/doi.org\/10.1186\/s43094-023-00512-1","journal-title":"Future J Pharm Sci"},{"key":"6147_CR122","doi-asserted-by":"publisher","first-page":"100040","DOI":"10.1016\/j.crphar.2021.100040","volume":"2","author":"PK Mante","year":"2021","unstructured":"Mante PK, Adomako NO, Antwi P, Kusi-Boadum NK (2021) Chronic administration of cryptolepine nanoparticle formulation alleviates seizures in a neurocysticercosis model. Curr Res Pharmacol Drug Discov 2:100040. https:\/\/doi.org\/10.1016\/j.crphar.2021.100040","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"6147_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36122","author":"C Jalili","year":"2024","unstructured":"Jalili C, Gholami M, Kakebaraei S (2024) Protective effect of crocin-loaded nanoparticles in rats following epileptic seizures: biochemical, behavioral and histopathological outcomes. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36122","journal-title":"Heliyon"},{"issue":"34","key":"6147_CR124","doi-asserted-by":"publisher","first-page":"21712","DOI":"10.1021\/acsomega.0c02618","volume":"5","author":"N Badawi","year":"2020","unstructured":"Badawi N, El-Say K, Attia D, El-Nabarawi M, Elmazar M, Teaima M (2020) Development of pomegranate extract-loaded solid lipid nanoparticles: quality by design approach to screen the variables affecting the quality attributes and characterization. ACS Omega 5(34):21712\u201321721. https:\/\/doi.org\/10.1021\/acsomega.0c02618","journal-title":"ACS Omega"},{"issue":"1","key":"6147_CR125","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12668-024-01624-5","volume":"15","author":"P Patel","year":"2025","unstructured":"Patel P, Vaidya R, Kansara Y, Shah P, Kapoor DU, Prajapati BG (2025) Multivariate optimization of carbamazepine-loaded nanostructured lipid carriers for brain targeting and epilepsy management. BioNanoScience 15(1):156. https:\/\/doi.org\/10.1007\/s12668-024-01624-5","journal-title":"BioNanoScience"},{"issue":"10","key":"6147_CR126","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/pharmaceutics13101640","volume":"13","author":"SC Nair","year":"2021","unstructured":"Nair SC, Vinayan KP, Mangalathillam S (2021) Nose to brain delivery of phenytoin sodium loaded nano lipid carriers: formulation, drug release, permeation and in vivo pharmacokinetic studies. Pharmaceutics 13(10):1640. https:\/\/doi.org\/10.3390\/pharmaceutics13101640","journal-title":"Pharmaceutics"},{"key":"6147_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.72.e153730","volume":"72","author":"R Bogdanova","year":"2025","unstructured":"Bogdanova R, Kondeva-Burdina M, Popova T, Tzankov B, Voycheva C, Slavkova M et al (2025) In vitro evaluation of antioxidant and neuroprotective effects of berberine loaded in nanostructured lipid carriers. Pharmacia 72:1\u201314. https:\/\/doi.org\/10.3897\/pharmacia.72.e153730","journal-title":"Pharmacia"},{"key":"6147_CR128","doi-asserted-by":"publisher","unstructured":"Satpathy B, Rajwar TK, Mishra A, Saha I, Rai VK, Sahoo RK, et al. Intra-nasal delivery of quercetin-loaded nanostructured lipid carriers (NLCs) in the management of Alzheimer\u2019s disease: formulation, in vitro and in vivo assessment. Mol Neurobiol. 2025:1\u201328. https:\/\/doi.org\/10.1007\/s12035-025-05137-4.","DOI":"10.1007\/s12035-025-05137-4"},{"issue":"1","key":"6147_CR129","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/pr13010112","volume":"13","author":"MS Costa","year":"2025","unstructured":"Costa MS, Ramos AM, Cardoso MM (2025) Drug release kinetics of PLGA-PEG microspheres encapsulating aclacinomycin A: the influence of PEG content. Processes 13(1):112. https:\/\/doi.org\/10.3390\/pr13010112","journal-title":"Processes"},{"issue":"4","key":"6147_CR130","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s10876-025-02851-w","volume":"36","author":"M Wu","year":"2025","unstructured":"Wu M, Xia J, Hu Y, Song H, Li W, Zhang W (2025) Box-Behnken optimized sustained-release PEG-PLGA nanoparticles for enhanced cytotoxicity of resveratrol against gastric cancer cells. J Clust Sci 36(4):140. https:\/\/doi.org\/10.1007\/s10876-025-02851-w","journal-title":"J Clust Sci"},{"issue":"3","key":"6147_CR131","doi-asserted-by":"publisher","first-page":"e0264825","DOI":"10.1371\/journal.pone.0264825","volume":"17","author":"NS Heredia","year":"2022","unstructured":"Heredia NS, Vizuete K, Flores-Calero M, Pazmi\u00f1o VK, Pilaquinga F, Kumar B et al (2022) Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly (lactic-co-glycolic acid). PLoS ONE 17(3):e0264825. https:\/\/doi.org\/10.1371\/journal.pone.0264825","journal-title":"PLoS ONE"},{"issue":"1","key":"6147_CR132","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/10717544.2022.2072413","volume":"29","author":"Y Su","year":"2022","unstructured":"Su Y, Liu J, Tan S, Liu W, Wang R, Chen C (2022) PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo. Drug Deliv 29(1):1437\u20131446. https:\/\/doi.org\/10.1080\/10717544.2022.2072413","journal-title":"Drug Deliv"},{"issue":"8","key":"6147_CR133","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C9RA10857B","volume":"10","author":"KY Hern\u00e1ndez-Giottonini","year":"2020","unstructured":"Hern\u00e1ndez-Giottonini KY, Rodr\u00edguez-C\u00f3rdova RJ, Guti\u00e9rrez-Valenzuela CA, Pe\u00f1u\u00f1uri-Miranda O, Zavala-Rivera P, Guerrero-Germ\u00e1n P et al (2020) PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Adv 10(8):4218\u20134231. https:\/\/doi.org\/10.1039\/C9RA10857B","journal-title":"RSC Adv"},{"key":"6147_CR134","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S245300","author":"C Schmitt","year":"2020","unstructured":"Schmitt C, Lechanteur A, Cossais F, Bellefroid C, Arnold P, Lucius R et al (2020) Liposomal encapsulated curcumin effectively attenuates neuroinflammatory and reactive astrogliosis reactions in glia cells and organotypic brain slices. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S245300","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"6147_CR135","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1038\/s41598-020-63894-9","volume":"10","author":"MH Shariare","year":"2020","unstructured":"Shariare MH, Rahman M, Lubna SR, Roy RS, Abedin J, Marzan AL et al (2020) Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model. Sci Rep 10(1):6938. https:\/\/doi.org\/10.1038\/s41598-020-63894-9","journal-title":"Sci Rep"},{"key":"6147_CR136","doi-asserted-by":"publisher","unstructured":"Chen L, Zhang Z, R. Simonsen M, Owens T, MH Khorooshi R, Wu C. PEGylated liposomes via ATRP for brain drug delivery. J Liposome Res. 2025:1\u20137. https:\/\/doi.org\/10.1080\/08982104.2025.2485428.","DOI":"10.1080\/08982104.2025.2485428"},{"issue":"8","key":"6147_CR137","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/pharmaceutics16080975","volume":"16","author":"W Song","year":"2024","unstructured":"Song W, Bai L, Xu P, Zhao Y, Zhou X, Xiong J et al (2024) Long-circulating and brain-targeted liposomes loaded with isoliquiritigenin: formation, characterization, pharmacokinetics, and distribution. Pharmaceutics 16(8):975. https:\/\/doi.org\/10.3390\/pharmaceutics16080975","journal-title":"Pharmaceutics"},{"issue":"3","key":"6147_CR138","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1007\/s12668-024-01532-8","volume":"14","author":"S Muthukrishnan","year":"2024","unstructured":"Muthukrishnan S, Gunasangkaran G, Ravi AK, Amirthalakshmi SR, Gandhi D, Arumugam VA et al (2024) Molecular mechanism of novel PAMAM dendrimer decorated Tectona grandis and Lactobacillus plantarum nanoparticles on autophagy-induced apoptosis in TNBC cells. BioNanoScience 14(3):2940\u20132963. https:\/\/doi.org\/10.1007\/s12668-024-01532-8","journal-title":"BioNanoScience"},{"key":"6147_CR139","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1039\/D5PM00119F","volume":"2","author":"T Suthar","year":"2025","unstructured":"Suthar T, Jain K (2025) Development and evaluation of N-acetyl cysteine-grafted polyamidoamine dendrimers for enhanced brain delivery of donepezil hydrochloride. RSC Pharm 2:1489\u20131499. https:\/\/doi.org\/10.1039\/D5PM00119F","journal-title":"RSC Pharm"},{"key":"6147_CR140","doi-asserted-by":"publisher","unstructured":"Huang AY-T, Kao C-L, Selvaraj A, Peng L. Solid-phase dendrimer synthesis: a promising approach to transform dendrimer construction. Mater Today Chem. 2023;27:101285. https:\/\/doi.org\/10.1016\/j.mtchem.2022.101285.","DOI":"10.1016\/j.mtchem.2022.101285"},{"key":"6147_CR141","doi-asserted-by":"publisher","unstructured":"Ahmed H, Singh S, Alexander A (2024) Inorganic nanoparticles for brain targeting scope and limitations. In: Alexander A (ed) Application of nanocarriers in brain delivery of therapeutics. Springer, Singapore, pp 187\u2013216. https:\/\/doi.org\/10.1007\/978-981-97-2859-6_7","DOI":"10.1007\/978-981-97-2859-6_7"},{"issue":"6","key":"6147_CR142","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1007\/s10311-021-01275-y","volume":"19","author":"A Pandey","year":"2021","unstructured":"Pandey A (2021) Cyclodextrin-based nanoparticles for pharmaceutical applications: a review. Environ Chem Lett 19(6):4297\u20134310. https:\/\/doi.org\/10.1007\/s10311-021-01275-y","journal-title":"Environ Chem Lett"},{"issue":"1","key":"6147_CR143","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12987-022-00369-1","volume":"19","author":"TA Arsiwala","year":"2022","unstructured":"Arsiwala TA, Sprowls SA, Blethen KE, Fladeland RA, Wolford CP, Kielkowski BN et al (2022) Characterization of passive permeability after low intensity focused ultrasound mediated blood\u2013brain barrier disruption in a preclinical model. Fluids Barriers CNS 19(1):72. https:\/\/doi.org\/10.1186\/s12987-022-00369-1","journal-title":"Fluids Barriers CNS"},{"key":"6147_CR144","doi-asserted-by":"publisher","unstructured":"Jindal A, Mainuddin, Kumar A, Ratnesh RK, Singh J. Nanotechnology driven lipid and metalloid based formulations targeting blood\u2013brain barrier (3B) for brain tumor. Indian J Microbiol. 2024:1\u201328. https:\/\/doi.org\/10.1007\/s12088-024-01330-6.","DOI":"10.1007\/s12088-024-01330-6"},{"key":"6147_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1069485","volume":"14","author":"VB Candido","year":"2023","unstructured":"Candido VB, Perego SM, Ceroni A, Metzger M, Colquhoun A, Michelini LC (2023) Trained hypertensive rats exhibit decreased transcellular vesicle trafficking, increased tight junctions\u2019 density, restored blood-brain barrier permeability and normalized autonomic control of the circulation. Front Physiol 14. https:\/\/doi.org\/10.3389\/fphys.2023.1069485","journal-title":"Front Physiol"},{"issue":"5","key":"6147_CR146","doi-asserted-by":"publisher","first-page":"R732","DOI":"10.1152\/ajpregu.00154.2020","volume":"321","author":"MG Fragas","year":"2021","unstructured":"Fragas MG, C\u00e2ndido VB, Davanzo GG, Rocha-Santos C, Ceroni A, Michelini LC (2021) Transcytosis within PVN capillaries: a mechanism determining both hypertension-induced blood-brain barrier dysfunction and exercise-induced correction. Am J Physiol Regul Integr Comp Physiol 321(5):R732\u2013R741. https:\/\/doi.org\/10.1152\/ajpregu.00154.2020","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"6147_CR147","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13578-023-01126-z","volume":"13","author":"HM Gao","year":"2023","unstructured":"Gao HM, Chen H, Cui GY, Hu JX (2023) Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke. Cell Biosci 13(1):196. https:\/\/doi.org\/10.1186\/s13578-023-01126-z","journal-title":"Cell Biosci"},{"issue":"11","key":"6147_CR148","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.3390\/ijms25115601","volume":"25","author":"S Dithmer","year":"2024","unstructured":"Dithmer S, Blasig IE, Fraser PA, Qin Z, Haseloff RF (2024) The basic requirement of tight junction proteins in blood-brain barrier function and their role in pathologies. Int J Mol Sci 25(11):5601. https:\/\/doi.org\/10.3390\/ijms25115601","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6147_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-021-00084-w","volume":"12","author":"Y-L Lo","year":"2021","unstructured":"Lo Y-L, Lin H-C, Hong S-T, Chang C-H, Wang C-S, Lin AM-Y (2021) Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood\u2013brain barrier model. Cancer Nanotechnol 12(1). https:\/\/doi.org\/10.1186\/s12645-021-00084-w","journal-title":"Cancer Nanotechnol"},{"issue":"2","key":"6147_CR150","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41551-022-00965-4","volume":"7","author":"T Kim","year":"2023","unstructured":"Kim T, Kim HJ, Choi W, Lee YM, Pyo JH, Lee J et al (2023) Deep brain stimulation by blood\u2013brain-barrier-crossing piezoelectric nanoparticles generating current and nitric oxide under focused ultrasound. Nat Biomed Eng 7(2):149\u2013163. https:\/\/doi.org\/10.1038\/s41551-022-00965-4","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"6147_CR151","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/pharmaceutics16020246","volume":"16","author":"KS Sung","year":"2024","unstructured":"Sung KS, Cho WH, Cha SH, Kim Y-W, Choi SH, Kim HJ et al (2024) Saturated fatty acid emulsions open the blood\u2013brain barrier and promote drug delivery in rat brains. Pharmaceutics 16(2):246. https:\/\/doi.org\/10.3390\/pharmaceutics16020246","journal-title":"Pharmaceutics"},{"key":"6147_CR152","doi-asserted-by":"publisher","unstructured":"Huang BX, Chen H, Joo Y, Kwon H-S, Fu C, Spector AA, et al. (2023) Interaction between GPR110 (ADGRF1) and tight junction protein occludin implicated in blood-brain barrier permeability. iScience 26(4). https:\/\/doi.org\/10.1016\/j.isci.2023.106550.","DOI":"10.1016\/j.isci.2023.106550"},{"issue":"6","key":"6147_CR153","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/13813455.2020.1784952","volume":"128","author":"B Zhao","year":"2022","unstructured":"Zhao B, Yin Q, Fei Y, Zhu J, Qiu Y, Fang W et al (2022) Research progress of mechanisms for tight junction damage on blood\u2013brain barrier inflammation. Arch Physiol Biochem 128(6):1579\u20131590. https:\/\/doi.org\/10.1080\/13813455.2020.1784952","journal-title":"Arch Physiol Biochem"},{"key":"6147_CR154","doi-asserted-by":"publisher","first-page":"215344","DOI":"10.1016\/j.ccr.2023.215344","volume":"494","author":"Q Tan","year":"2023","unstructured":"Tan Q, Zhao S, Xu T, Wang Q, Zhang M, Yan L et al (2023) Inorganic nano-drug delivery systems for crossing the blood\u2013brain barrier: advances and challenges. Coord Chem Rev 494:215344. https:\/\/doi.org\/10.1016\/j.ccr.2023.215344","journal-title":"Coord Chem Rev"},{"key":"6147_CR155","doi-asserted-by":"publisher","first-page":"112111","DOI":"10.1016\/j.eurpolymj.2023.112111","volume":"193","author":"J Ahamed","year":"2023","unstructured":"Ahamed J, Gowda BJ, Almalki WH, Gupta N, Sahebkar A, Kesharwani P (2023) Recent advances in nanoparticle-based approaches for the treatment of brain tumors: opportunities and challenges. Eur Polym J 193:112111. https:\/\/doi.org\/10.1016\/j.eurpolymj.2023.112111","journal-title":"Eur Polym J"},{"issue":"1","key":"6147_CR156","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12987-025-00693-2","volume":"22","author":"G Bonvicini","year":"2025","unstructured":"Bonvicini G, Singh S, Sandersj\u00f6\u00f6 L, Dallas T, Schlein E, Dahl\u00e9n AD et al (2025) High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose. Fluids Barriers CNS 22(1):86. https:\/\/doi.org\/10.1186\/s12987-025-00693-2","journal-title":"Fluids Barriers CNS"},{"key":"6147_CR157","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s13346-025-01811-1","volume":"15","author":"JI Morrison","year":"2025","unstructured":"Morrison JI, Metzendorf NG, Liu J, Hultqvist G (2025) Serotransferrin enhances transferrin receptor-mediated brain uptake of antibodies. Drug Deliv Transl Res 15:3321\u20133337. https:\/\/doi.org\/10.1007\/s13346-025-01811-1","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"6147_CR158","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H, Li H, Wong K-L, All AH (2024) Functionalized nanomaterials capable of crossing the blood\u2013brain barrier. ACS Nano 18(3):1820\u20131845. https:\/\/doi.org\/10.1021\/acsnano.3c10674","journal-title":"ACS Nano"},{"issue":"7","key":"6147_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071392","volume":"11","author":"S Latif","year":"2022","unstructured":"Latif S, Choi S-H, Gyawali A, Hyeon SJ, Kang Y-S, Ryu H (2022) Antioxidant and neuroprotective effects of paeonol against oxidative stress and altered carrier-mediated transport system on NSC-34 cell lines. Antioxidants (Basel) 11(7). https:\/\/doi.org\/10.3390\/antiox11071392","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"6147_CR160","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/futurepharmacol4030027","volume":"4","author":"T Tashima","year":"2024","unstructured":"Tashima T (2024) Substance delivery across the blood-brain barrier or the blood-retinal barrier using organic cation transporter novel type 2 (OCTN2). Future Pharmacol 4(3):479\u2013493. https:\/\/doi.org\/10.3390\/futurepharmacol4030027","journal-title":"Future Pharmacol"},{"key":"6147_CR161","doi-asserted-by":"publisher","first-page":"113565","DOI":"10.1016\/j.jep.2020.113565","volume":"268","author":"J Kaur","year":"2021","unstructured":"Kaur J, Famta P, Famta M, Mehta M, Satija S, Sharma N et al (2021) Potential anti-epileptic phytoconstituents: an updated review. J Ethnopharmacol 268:113565. https:\/\/doi.org\/10.1016\/j.jep.2020.113565","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"6147_CR162","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/17425247.2021.1823965","volume":"18","author":"M Shringarpure","year":"2021","unstructured":"Shringarpure M, Gharat S, Momin M, Omri A (2021) Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opin Drug Deliv 18(2):169\u2013185. https:\/\/doi.org\/10.1080\/17425247.2021.1823965","journal-title":"Expert Opin Drug Deliv"},{"key":"6147_CR163","doi-asserted-by":"publisher","unstructured":"Nguyen T-T-L, Maeng H-J. Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery. Pharmaceutics. 2022;14(3):572. https:\/\/doi.org\/10.3390\/pharmaceutics14030572.","DOI":"10.3390\/pharmaceutics14030572"},{"issue":"2","key":"6147_CR164","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s13346-024-01610-0","volume":"15","author":"JR Youssef","year":"2025","unstructured":"Youssef JR, Boraie NA, Ismail FA, Bakr BA, Allam EA, El-Moslemany RM (2025) Brain targeted lactoferrin coated lipid nanocapsules for the combined effects of apocynin and lavender essential oil in PTZ induced seizures. Drug Deliv Transl Res 15(2):534\u2013555. https:\/\/doi.org\/10.1007\/s13346-024-01610-0","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"6147_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040727","volume":"11","author":"Y-W Lin","year":"2022","unstructured":"Lin Y-W, Fang C-H, Yang C-Y, Liang Y-J, Lin F-H (2022) Investigating a curcumin-loaded PLGA-PEG-PLGA thermo-sensitive hydrogel for the prevention of Alzheimer\u2019s disease. Antioxidants (Basel) 11(4). https:\/\/doi.org\/10.3390\/antiox11040727","journal-title":"Antioxidants (Basel)"},{"key":"6147_CR166","doi-asserted-by":"publisher","first-page":"126471","DOI":"10.1016\/j.ijbiomac.2023.126471","volume":"252","author":"S Sharma","year":"2023","unstructured":"Sharma S, Tyagi A, Dang S (2023) Nose to brain delivery of transferrin conjugated PLGA nanoparticles for clonidine. Int J Biol Macromol 252:126471. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126471","journal-title":"Int J Biol Macromol"},{"key":"6147_CR167","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2024.07.014","volume":"373","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chu Y, Li C, Fan L, Lu H, Zhan C et al (2024) Brain-targeted drug delivery by in vivo functionalized liposome with stable D-peptide ligand. J Control Release 373:240\u2013251. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.014","journal-title":"J Control Release"},{"issue":"1","key":"6147_CR168","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/biomimetics10010025","volume":"10","author":"H Sharma","year":"2025","unstructured":"Sharma H, Narayanan KB, Ghosh S, Singh KK, Rehan P, Amist AD et al (2025) Nanotherapeutics for meningitis: enhancing drug delivery across the blood-brain barrier. Biomimetics 10(1):25. https:\/\/doi.org\/10.3390\/biomimetics10010025","journal-title":"Biomimetics"},{"issue":"6","key":"6147_CR169","doi-asserted-by":"publisher","first-page":"e0325772","DOI":"10.1371\/journal.pone.0325772","volume":"20","author":"A Zeb","year":"2025","unstructured":"Zeb A, Ali H, Khan JZ, Shah FA, Alattar A, Alanazi FE (2025) In silico molecular docking and molecular dynamic simulation of transferrin coated phenytoin loaded SLNs with molecular targets of epilepsy. PLoS ONE 20(6):e0325772. https:\/\/doi.org\/10.1371\/journal.pone.0325772","journal-title":"PLoS ONE"},{"key":"6147_CR170","doi-asserted-by":"publisher","unstructured":"Elsayyad NME, Elkady OA, Swidan MM, Rashed HM, Sakr TM, Abdelhamid AM, et al. (2025) Zonisamide nanodiamonds for brain targeting: a comprehensive study utilising in silico, in vitro, in vivo, and molecular investigation for successful nose-to-brain delivery for epilepsy management. Drug Deliv Transl Res. 1\u201324. https:\/\/doi.org\/10.1007\/s13346-025-01904-x.","DOI":"10.1007\/s13346-025-01904-x"},{"issue":"9","key":"6147_CR171","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/17425255.2021.1959912","volume":"17","author":"K \u0141ukawski","year":"2021","unstructured":"\u0141ukawski K, Czuczwar SJ (2021) Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it. Expert Opin Drug Metab Toxicol 17(9):1075\u20131090. https:\/\/doi.org\/10.1080\/17425255.2021.1959912","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"6147_CR172","doi-asserted-by":"publisher","first-page":"a022780","DOI":"10.1101\/cshperspect.a022780","volume":"6","author":"MA Rogawski","year":"2016","unstructured":"Rogawski MA, L\u00f6scher W, Rho JM (2016) Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb Perspect Med 6(5):a022780. https:\/\/doi.org\/10.1101\/cshperspect.a022780","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"6147_CR173","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00774-023-01475-2","volume":"42","author":"SJ DeShazo","year":"2024","unstructured":"DeShazo SJ, Ozmer GL, Horton KA, Weiss WM (2024) Phenytoin is associated with increased risk of osteoporosis and fragility fractures in adult epileptic patients. J Bone Miner Metab 42(1):69\u201376. https:\/\/doi.org\/10.1007\/s00774-023-01475-2","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"6147_CR174","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ene.13811","volume":"26","author":"R Stevelink","year":"2019","unstructured":"Stevelink R, Koeleman B, Sander J, Jansen F, Braun K (2019) Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors. Eur J Neurol 26(6):856\u2013864. https:\/\/doi.org\/10.1111\/ene.13811","journal-title":"Eur J Neurol"},{"issue":"1","key":"6147_CR175","doi-asserted-by":"publisher","first-page":"14239","DOI":"10.1038\/s41598-024-65301-z","volume":"14","author":"N Kabiri-Samani","year":"2024","unstructured":"Kabiri-Samani N, Amini-Khoei H, Rahimi-Madiseh M, Sureda A, Lorigooini Z (2024) Trigonelline as an anticonvulsant agent: mechanistic insights into NMDA receptor expression and oxidative stress balance. Sci Rep 14(1):14239. https:\/\/doi.org\/10.1038\/s41598-024-65301-z","journal-title":"Sci Rep"},{"key":"6147_CR176","doi-asserted-by":"publisher","first-page":"1792829","DOI":"10.3389\/fneur.2026.1792829","volume":"17","author":"A Naim","year":"2026","unstructured":"Naim A, Farooqui AM, Badruddeen Khan MI, Akhtar J, Ahmad A, Ashique S, Islam A (2026) Nanoengineered phytochemicals overcome blood\u2013brain barrier constraints in neurodegenerative disorders. Front Neurol 17:1792829. https:\/\/doi.org\/10.3389\/fneur.2026.1792829","journal-title":"Front Neurol"},{"issue":"11","key":"6147_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113561","volume":"27","author":"S Mehan","year":"2022","unstructured":"Mehan S, Arora N, Bhalla S, Khan A, U Rehman M, Alghamdi BS et al (2022) Involvement of phytochemical-encapsulated nanoparticles\u2019 interaction with cellular signalling in the amelioration of benign and malignant brain tumours. Molecules 27(11). https:\/\/doi.org\/10.3390\/molecules27113561","journal-title":"Molecules"},{"issue":"8","key":"6147_CR178","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1021\/acschemneuro.2c00171","volume":"13","author":"MA Siddiqui","year":"2022","unstructured":"Siddiqui MA, Asad M, Akhter J, Hoda U, Rastogi S, Arora I et al (2022) Resveratrol-loaded glutathione-coated collagen nanoparticles attenuate acute seizures by inhibiting HMGB1 and TLR-4 in the hippocampus of mice. ACS Chem Neurosci 13(8):1342\u20131354. https:\/\/doi.org\/10.1021\/acschemneuro.2c00171","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"6147_CR179","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/17425247.2023.2153831","volume":"20","author":"MY George","year":"2023","unstructured":"George MY, El-Derany MO, Ahmed Y, Zaher M, Ibrahim C, Waleed H et al (2023) Design and evaluation of chrysin-loaded nanoemulsion against lithium\/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative stress, microglia polarization, and AMPK\/SIRT-1\/PGC-1\u03b1 pathway. Expert Opin Drug Deliv 20(1):159\u2013174. https:\/\/doi.org\/10.1080\/17425247.2023.2153831","journal-title":"Expert Opin Drug Deliv"},{"key":"6147_CR180","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejpb.2023.04.008","volume":"188","author":"AE El-Nahas","year":"2023","unstructured":"El-Nahas AE, Elbedaiwy HM, Masoud IM, Aly RG, Helmy MW, El-Kamel AH (2023) Berberine-loaded zein\/hyaluronic acid composite nanoparticles for efficient brain uptake to alleviate neuro-degeneration in the pilocarpine model of epilepsy. Eur J Pharm Biopharm 188:182\u2013200. https:\/\/doi.org\/10.1016\/j.ejpb.2023.04.008","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"6147_CR181","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s11064-023-03967-z","volume":"48","author":"L Saha","year":"2023","unstructured":"Saha L, Kumari P, Rawat K, Gautam V, Sandhu A, Singh N et al (2023) Neuroprotective effect of berberine nanoparticles against seizures in pentylenetetrazole induced kindling model of epileptogenesis: role of anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. Neurochem Res 48(10):3055\u20133072. https:\/\/doi.org\/10.1007\/s11064-023-03967-z","journal-title":"Neurochem Res"},{"key":"6147_CR182","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5c00452","author":"L Wang","year":"2025","unstructured":"Wang L, Yang L, Liang K, Liu B, Luo Q, Wang W et al (2025) Cannabidiol-loaded nanostructured lipid carriers for nose to brain delivery: an effective therapeutic approach against epilepsy. Mol Pharm. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00452","journal-title":"Mol Pharm"},{"issue":"5","key":"6147_CR183","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1208\/s12249-025-03119-2","volume":"26","author":"P Pradhan","year":"2025","unstructured":"Pradhan P, Rai VK, Halder J, Kar D, Prusty SK, Rout SK et al (2025) Development and characterization of chitosan nanoparticles containing quercetin-\u03b2-cyclodextrin inclusion complex for improved solubility, brain targeting, and neuroprotective potential against epilepsy. AAPS PharmSciTech 26(5):124. https:\/\/doi.org\/10.1208\/s12249-025-03119-2","journal-title":"AAPS PharmSciTech"},{"key":"6147_CR184","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S218317","author":"M Hashemian","year":"2019","unstructured":"Hashemian M, Ghasemi-Kasman M, Ghasemi S, Akbari A, Moalem-Banhangi M, Zare L et al (2019) Fabrication and evaluation of novel quercetin-conjugated Fe3O4\u2013\u03b2-cyclodextrin nanoparticles for potential use in epilepsy disorder. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S218317","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"6147_CR185","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s13346-025-01937-2","volume":"16","author":"JR Youssef","year":"2026","unstructured":"Youssef JR, Boraie NA, Ismail FA, Bakr BA, Allam EA, Agami MA, El-Moslemany RM (2026) Mannosylated fisetin\/carveol lipid nanocapsules: brain-targeted dual therapy for modulation of epileptogenesis and cognitive deficits. Drug Deliv Translat Res 16(5):1349\u201371. https:\/\/doi.org\/10.1007\/s13346-025-01937-2","journal-title":"Drug Deliv Translat Res"},{"key":"6147_CR186","doi-asserted-by":"publisher","unstructured":"Mahawar S, Rakshit D, Patel I, Gore SK, Sen S, Ranjan OP et al. (2024) Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS\/TNF-\u03b1-NLRP3 inflammasomes pathway. Nanomedicine: Nanotechnology, Biol Medic 59:102752. https:\/\/doi.org\/10.1016\/j.nano.2024.102752.","DOI":"10.1016\/j.nano.2024.102752"},{"issue":"6","key":"6147_CR187","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/ph18060782","volume":"18","author":"PEA de Aquino","year":"2025","unstructured":"de Aquino PEA, J\u00fanior FJG, de Souza NT, Rosal Lustosa \u00cd, de Andrade GM, Ricardo NMPS et al (2025) Nanoemulsions of cannabidiol, \u03949-tetrahydrocannabinol, and their combination similarly exerted anticonvulsant and antioxidant effects in mice treated with pentyelenetetrazole. Pharmaceuticals 18(6):782. https:\/\/doi.org\/10.3390\/ph18060782","journal-title":"Pharmaceuticals"},{"issue":"1","key":"6147_CR188","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41598-024-51483-z","volume":"14","author":"H Alizadeh","year":"2024","unstructured":"Alizadeh H, Ahmadi M, Heydari SO (2024) On chip synthesis of a pH sensitive gefitinib anticancer drug nanocarrier based on chitosan\/alginate natural polymers. Sci Rep 14(1):772. https:\/\/doi.org\/10.1038\/s41598-024-51483-z","journal-title":"Sci Rep"},{"issue":"39","key":"6147_CR189","doi-asserted-by":"publisher","first-page":"16016","DOI":"10.1039\/d3nr02874g","volume":"15","author":"HM Pagendarm","year":"2023","unstructured":"Pagendarm HM, Stone PT, Kimmel BR, Baljon JJ, Aziz MH, Pastora LE et al (2023) Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing. Nanoscale 15(39):16016\u201316029. https:\/\/doi.org\/10.1039\/d3nr02874g","journal-title":"Nanoscale"},{"key":"6147_CR190","doi-asserted-by":"publisher","unstructured":"Hassan D, Sani A, Medina DI (2023) Limitations of nanocarriers such as cell and tissue toxicity, genotoxicity, scale-up of nanomaterials. In: Khan FA (ed) Nano drug delivery for cancer therapy: principles and practices. Springer, Singapore, pp 149\u2013171. https:\/\/doi.org\/10.1007\/978-981-99-6940-1_8","DOI":"10.1007\/978-981-99-6940-1_8"},{"key":"6147_CR191","doi-asserted-by":"publisher","first-page":"120807","DOI":"10.1016\/j.ijpharm.2021.120807","volume":"605","author":"MC Operti","year":"2021","unstructured":"Operti MC, Bernhardt A, Grimm S, Engel A, Figdor CG, Tagit O (2021) PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up. Int J Pharm 605:120807. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120807","journal-title":"Int J Pharm"},{"issue":"3","key":"6147_CR192","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/polym15030782","volume":"15","author":"D Pasarin","year":"2023","unstructured":"Pasarin D, Ghizdareanu A-I, Enascuta CE, Matei CB, Bilbie C, Paraschiv-Palada L et al (2023) Coating materials to increase the stability of liposomes. Polymers 15(3):782. https:\/\/doi.org\/10.3390\/polym15030782","journal-title":"Polymers"},{"issue":"6","key":"6147_CR193","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/pharmaceutics13060770","volume":"13","author":"PM Perrigue","year":"2021","unstructured":"Perrigue PM, Murray RA, Mielcarek A, Henschke A, Moya SE (2021) Degradation of drug delivery nanocarriers and payload release: a review of physical methods for tracing nanocarrier biological fate. Pharmaceutics 13(6):770. https:\/\/doi.org\/10.3390\/pharmaceutics13060770","journal-title":"Pharmaceutics"},{"issue":"8","key":"6147_CR194","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2174\/0115680266287101240214071718","volume":"24","author":"K Mahajan","year":"2024","unstructured":"Mahajan K, Bhattacharya S (2024) The advancement and obstacles in improving the stability of nanocarriers for precision drug delivery in the field of nanomedicine. Curr Top Med Chem 24(8):686\u2013721. https:\/\/doi.org\/10.2174\/0115680266287101240214071718","journal-title":"Curr Top Med Chem"},{"key":"6147_CR195","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.2147\/IJN.S267007","volume":"15","author":"J Fonseca-Gomes","year":"2020","unstructured":"Fonseca-Gomes J, Loureiro JA, Tanqueiro SR, Mouro FM, Ruivo P, Carvalho T et al (2020) In vivo bio-distribution and toxicity evaluation of polymeric and lipid-based nanoparticles: a potential approach for chronic diseases treatment. Int J Nanomed 15:8609\u20138621. https:\/\/doi.org\/10.2147\/IJN.S267007","journal-title":"Int J Nanomed"},{"key":"6147_CR196","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S443168","author":"K Jakic","year":"2024","unstructured":"Jakic K, Selc M, Razga F, Nemethova V, Mazancova P, Havel F et al (2024) Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S443168","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"6147_CR197","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11051-024-05983-8","volume":"26","author":"A Alqudah","year":"2024","unstructured":"Alqudah A, Aljabali AA, Gammoh O, Tambuwala MM (2024) Advancements in neurotherapeutics: nanoparticles overcoming the blood\u2013brain barrier for precise CNS targeting. J Nanoparticle Res 26(6):123. https:\/\/doi.org\/10.1007\/s11051-024-05983-8","journal-title":"J Nanoparticle Res"},{"issue":"1","key":"6147_CR198","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","volume":"23","author":"S Liu","year":"2025","unstructured":"Liu S, Jin X, Ge Y, Dong J, Liu X, Pei X et al (2025) Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability. J Nanobiotechnology 23(1):382. https:\/\/doi.org\/10.1186\/s12951-025-03415-w","journal-title":"J Nanobiotechnology"},{"key":"6147_CR199","doi-asserted-by":"publisher","first-page":"1127460","DOI":"10.3389\/fnins.2023.1127460","volume":"17","author":"S Zia","year":"2023","unstructured":"Zia S, Islam Aqib A, Muneer A, Fatima M, Atta K, Kausar T et al (2023) Insights into nanoparticles-induced neurotoxicity and cope up strategies. Front Neurosci 17:1127460. https:\/\/doi.org\/10.3389\/fnins.2023.1127460","journal-title":"Front Neurosci"},{"issue":"29","key":"6147_CR200","doi-asserted-by":"publisher","first-page":"2502315","DOI":"10.1002\/smll.202502315","volume":"21","author":"N Desai","year":"2025","unstructured":"Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK (2025) Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape. Small 21(29):2502315. https:\/\/doi.org\/10.1002\/smll.202502315","journal-title":"Small"},{"issue":"15","key":"6147_CR201","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","volume":"20","author":"B Mangla","year":"2025","unstructured":"Mangla B, Kumar P, Javed S, Pathan T, Ahsan W, Aggarwal G (2025) Regulating nanomedicines: challenges, opportunities, and the path forward. Nanomedicine 20(15):1911\u20131927. https:\/\/doi.org\/10.1080\/17435889.2025.2533107","journal-title":"Nanomedicine"},{"issue":"1","key":"6147_CR202","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3762\/bjnano.15.118","volume":"15","author":"I Rahat","year":"2024","unstructured":"Rahat I, Yadav P, Singhal A, Fareed M, Purushothaman JR, Aslam M et al (2024) Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects. Beilstein J Nanotechnol 15(1):1473\u20131497. https:\/\/doi.org\/10.3762\/bjnano.15.118","journal-title":"Beilstein J Nanotechnol"},{"key":"6147_CR203","doi-asserted-by":"publisher","first-page":"953205","DOI":"10.3389\/fphar.2022.953205","volume":"13","author":"M Heinrich","year":"2022","unstructured":"Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kuli\u0107 \u017d, McGaw LJ et al (2022) Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research\u2014the ConPhyMP\u2014guidelines. Front Pharmacol 13:953205. https:\/\/doi.org\/10.3389\/fphar.2022.953205","journal-title":"Front Pharmacol"},{"issue":"2","key":"6147_CR204","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11101-023-09894-9","volume":"23","author":"P Upadhyay","year":"2024","unstructured":"Upadhyay P, Ghosh A, Sarangthem V, Singh TD (2024) Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way. Phytochem Rev 23(2):485\u2013527. https:\/\/doi.org\/10.1007\/s11101-023-09894-9","journal-title":"Phytochem Rev"},{"issue":"4","key":"6147_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040464","volume":"17","author":"S Jacob","year":"2025","unstructured":"Jacob S, Kather FS, Boddu SH, Rao R, Nair AB (2025) Vesicular carriers for phytochemical delivery: a comprehensive review of techniques and applications. Pharmaceutics 17(4). https:\/\/doi.org\/10.3390\/pharmaceutics17040464","journal-title":"Pharmaceutics"},{"issue":"1","key":"6147_CR206","doi-asserted-by":"publisher","first-page":"2645830","DOI":"10.1080\/10717544.2026.2645830","volume":"33","author":"J Li","year":"2026","unstructured":"Li J, Guo L, Cai W, Mei J, Liu J, Liu Y (2026) Overcoming the blood-brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer\u2019s disease. Drug Deliv 33(1):2645830. https:\/\/doi.org\/10.1080\/10717544.2026.2645830","journal-title":"Drug Deliv"},{"key":"6147_CR207","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1591438","volume":"16","author":"K Wang","year":"2025","unstructured":"Wang K, Yang R, Li J, Wang H, Wan L, He J (2025) Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1591438","journal-title":"Front Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06147-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:42:54Z","timestamp":1787870574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06147-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":207,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6147"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06147-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"861"}}